|
LOC389333 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87108999999408E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.415400E-04 |
| Normal-vs-Stage2 |
3.68699999999667E-05 |
| Normal-vs-Stage3 |
4.03900000001123E-07 |
| Normal-vs-Stage4 |
6.65910000030578E-07 |
| Stage1-vs-Stage2 |
7.873500E-02 |
| Stage1-vs-Stage3 |
5.553600E-04 |
| Stage1-vs-Stage4 |
1.738280E-03 |
| Stage2-vs-Stage3 |
6.859600E-01 |
| Stage2-vs-Stage4 |
7.418000E-01 |
| Stage3-vs-Stage4 |
9.262400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88459999997492E-06 |
| Normal-vs-AfricanAmerican |
1.540210E-01 |
| Normal-vs-Asian |
1.528110E-02 |
| Caucasian-vs-AfricanAmerican |
1.159980E-02 |
| Caucasian-vs-Asian |
6.692800E-01 |
| AfricanAmerican-vs-Asian |
2.080600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3979999999858E-06 |
| Normal-vs-Female |
8.243300E-04 |
| Male-vs-Female |
4.236900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.759900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.89180000000189E-05 |
| Normal-vs-Age(61-80Yrs) |
3.65579999994647E-06 |
| Normal-vs-Age(81-100Yrs) |
1.352350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.746000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.056800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.343400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.626000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.080600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.277000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.785000E-01 |
| Normal-vs-Grade 2 |
4.152400E-04 |
| Normal-vs-Grade 3 |
1.65149999997727E-06 |
| Normal-vs-Grade 4 |
4.65489999879054E-08 |
| Grade 1-vs-Grade 2 |
4.588100E-02 |
| Grade 1-vs-Grade 3 |
4.233200E-04 |
| Grade 1-vs-Grade 4 |
2.584600E-03 |
| Grade 2-vs-Grade 3 |
1.121640E-02 |
| Grade 2-vs-Grade 4 |
5.58529999999946E-05 |
| Grade 3-vs-Grade 4 |
4.746500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.1588999999933E-05 |
| Normal-vs-ccB subtype |
1.72009999999112E-05 |
| ccA subtype-vs-ccB subtype |
5.841000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54031999999305E-05 |
| Normal-vs-N1 |
1.574220E-04 |
| N0-vs-N1 |
4.631800E-01 |
|
|
